US Patent Issued to Regents of the University of Minnesota on Oct. 21 for "Transplant tolerance induction with carbodiimide treated tolerizing vaccine" (Minnesota Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,437, issued on Oct. 21, was assigned to Regents of the University of Minnesota (Minneapolis).

"Transplant tolerance induction with carbodiimide treated tolerizing vaccine" was invented by Bernhard J. Hering (Minneapolis) and Sabarinathan Ramachandran (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is related to compositions and systems for inducing immune tolerance for transplanted cells, organ, or tissues in a transplant recipient. Also provided herein are methods of making and methods of administering tolerizing vaccines/regimen or preparatory regimens."

The patent was filed on April 13, 2021, under Application ...